SIGMA-ALDRICH search Sigma-Aldrich VIM products
includes other brands or spellings
|
| ic, wb | | Sigma mouse anti-human monoclonal vimentin antibody (V6630) was used in western blot and immunocytochemistry to study transforming growth factor-beta responses in smooth muscle cell. |
| ic | | Sigma mouse anti-vimentin monoclonal antibody (clone V9) was used in immunocytochemistry to detect the effects of hNFL mutations on co-assembly with vimentin in SW13 Vim+ human adrenal carcinoma cells. |
| ic | | Sigma anti-vimentin antibody was used in New Zealand white rabbits renal proximal tubular cell (RPTCs, which were infected with recombinant adenovirus expressing kinase inactive form of human p38) and in immunocytochemistry to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury. |
| ic | | Sigma anti-vimentin antibody was used in african monkey kidney cell line COS-7 with human wild type alpha-syn cDNA and in immunocytochemistry to study the effects of inhibitors of the mitochondrial electron-transport chain on the aggregation of -synuclein. |
| ic | | Sigma monoclonal anti-vimentin antibody clone V9 (1:100) was used in immunofluorescence as a marker of the intermediate filament network to study the redistribution of vimentin in cells expressing mutant ELOVL4. |
| ih | | Sigma vimentin monoclonal antibody was used in immunohistochemistry to study human placentation. |
| ih | | Sigma VIM antibody was tested in immunohistochemistry by Human Protein Atlas. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology VIM products
includes other brands or spellings
|
| ic, wb | | Santa Cruz anti-vimentin antibody was used in human HMEC-1 cells and C166 cells and in immunocytochemistry, western blot to study the role of DP in capillary formation/stabilization. |
| ih | | Santa Cruz Biotechnology affinity-purified polyclonal vimentin antibody was used in immunohistochemistry to study integrin-dependent NOV (CCN3) functions in wound healing. |
INVITROGEN search Invitrogen VIM products
includes other brands or spellings
|
| ic | | Zymed anti-Vimentin antibody was used in immunocytochemistry to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific VIM products
includes other brands or spellings
|
| wb | | Lab Vision Vimentin Ab-2 antibody was tested in western blot by Abminer. |
PROGEN search Progen VIM products
includes other brands or spellings
|
| ic | | Progen mouse monoclonal anti-vimentin antibody was used in immunocytochemistry to study MRP2 mutation. |
| ic | | Progen Biotechnik FITC-conjugated mouse anti-human vimentin mAb (clone 3B4, IgG2a) was used in immunocytochemistry to study the acquisition of a chemokine receptor named CCR1 as trophoblasts differentiate towards invasive phenotype. |
BECKMAN COULTER search Beckman Coulter VIM products
includes other brands or spellings
|
| ic | | Dako anti-vimentin antibody was used in human Kaposi's sarcoma cells (KS cells) and in immunocytochemistry to study the molecular mechanisms through which HIV-1-Tat protein inhibits vincristine-induced apoptosis of KS cells. |
| ic | | Dako mouse monoclonal anti-vimentin antibody was used in human MRC5 cells and in immunocytometry to study the role for antivimentin antibody in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. |
| ic | | DAKO vimentin antibody was used in immunocytochemistry to study cardiotrophin-1 effect on cardiac fibroblast growth. |
| ic | | DAKO anti-vimentin antibody was used in immunocytochemistry to study the relationship between FPR expression and the biologic behavior of glioma cells. |
| ic | | Dako mouse monoclonal antivimentin antibody (clone V9) was used in immunocytochemistry to study the possible correlation of the antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma with FGF receptor expression and tumor variant. |
| ih | | DakoCytomation VIM antibody was tested in immunohistochemistry by HPA (HPA001762) . |
| ih | | Beckman Coulter mouse monoclonal anti-vimentin antibody V9 was used in immunohistochemistry to study the expression of putative LMX1B in nail-patella syndrome kidneys. |
| ih | | DAKO mouse monoclonal anti-vimentin antibody was used in immunohistochemistry to localize amnion mesenchymal cells in human placental tissue. |
| ih | | Dako Diagnostics mouse vimentin antibody (M7020) was used in immunohistochemistry to study activation of enteric neurons and enteric glia in the guinea pig ileum and colon by IL1B. |
| ih | | Dako mouse anti-human vimentin mAb (clone V9, IgG1) was used in immunohistochemistry to study the acquisition of a chemokine receptor named CCR1 as trophoblasts differentiate towards invasive phenotype. |
| ih | | DAKO anti-vimentin antibody was used in immunohistochemistry to identify a series of genetic events leading to translocation, deletion/amplification, and overexpression of the HMGIC and MDM2 genes in a carcinoma ex pleomorphic adenoma (CexPA) at an early stage of development. |
| ih | | Dako vimentin antibody was used in immunohistochemistry to study SFTPC gene mutation in an interstitial lung disease patient. |
| wb | | Dako vimentin monoclonal antibody was used in western blot to study the interaction between hamartin and neurofilament-L. |
BIOMEDA search Biomeda VIM products
|
| block | | Biomeda rabbit antisera to human vimentin was used in blocking experiment to neutralize vimentin activity on CHO-KI cells. |
BIOGENEX search Biogenex VIM products
includes other brands or spellings
|
| ih | | BioGenex Laboratories anti-vimentin antibody was used in immunohistochemistry to study the down-regulation of iNOS expression by MDA-7 in melanoma cells. |
| ih | | BioGenex Laboratories antivimentin antibodies were used in immunohistochemistry to study the loss of MDA-7 expression with progression of melanoma. |
ROCHE APPLIED SCIENCE search Roche Applied Science VIM products
includes other brands or spellings
|
| ic | | Roche Molecular Biochemicals monoclonal antibody directed against vimentin was used in immunocytochemistry to provide the first evidence that the tumor suppressor nm23-H2 could act on beta1 integrin-mediated cell adhesion by interacting with one of the integrin partners ICAP-1alpha. |
ALEXIS CORP
|
| elisa, ic | | Alexis Corp. anti-vimentin antibody was used in cytotrophoblast from human and in immunocytochemistry to study the role for MRP5 in human placenta and cultured human trophoblasts. |
RESEARCH DIAGNOSTICS
|
| flow | | Research Diagnostics FITC anti-vimentin was used in flow cytometry to determine vimentin expression on the surface of human monocytes. |
YLEM SRL
|
| elisa, wb | | YLEM s.r.l. mouse monoclonal anti-human vimentin antibody was used in human MRC5 cells and in western blot, ELISA to study the role for antivimentin antibody in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. |
Articles Reviewed |
| 1. He-Jin Lee et al. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. 2002 |
| 2. Sabine M Duplan et al. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. 2002 |
| 3. Toshihiro Tsuruda et al. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. 2002 |
| 4. Eva Röijer et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. 2002 |
| 5. Julie A Ellerhorst et al. Loss of MDA-7 expression with progression of melanoma. 2002 |
| 6. Henri-Noël Fournier et al. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. 2002 |
| 7. Y Yang et al. Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. 2002 |
| 8. Maria Chiara Deregibus et al. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. 2002 |
| 9. Xiaojuan Yan et al. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. 2002 |
| 10. Luciana A Haddad et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. 2002 |
| 11. Verena Keitel et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). 2003 |
| 12. Raul Perez-Olle et al. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. 2002 |
| 13. Suhendan Ekmekcioglu et al. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. 2003 |
| 14. Rachel C Chambers et al. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. 2003 |
| 15. Laurence Heidet et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. 2003 |
| 16. Eric T T L Tjwa et al. Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon. 2003 |
| 17. Hideki Koi et al. Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. 2003 |
| 18. Yukiyasu Sato et al. Trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards invasive phenotype. 2003 |
| 19. Xuan Zhou et al. Desmoplakin is required for microvascular tube formation in culture. 2004 |
| 20. F Brasch et al. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. 2004 |
| 21. Cristiane G Lin et al. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. 2005 |
| 22. Henriette E U Meyer Zu Schwabedissen et al. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. 2005 |
| 23. Shougang Zhuang et al. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. 2005 |
| 24. Xiaoping Chen et al. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. 2005 |
| 25. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 |
| 26. Celene Grayson et al. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. 2005 |
| 27. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 28. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 29. Ankita Garg et al. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. 2006 |